# Xencor (XNCR) — News

XNCR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/xncr/news

## Recent headlines

- [Xencor Q2 net income USD -21.729 million](https://www.ainvest.com/news/xencor-q2-net-income-usd-21-729-million-2608) — AInvest Wire, Aug 5, 2026
- [Xencor extends cash runway estimate through 2028](https://www.ainvest.com/news/xencor-extends-cash-runway-estimate-2028-2607) — AInvest Wire, Jul 29, 2026
  Xencor, Inc. (NASDAQ: XNCR) has updated its cash runway forecast, projecting that its existing cash and cash equivalents will be sufficient to fund operations through 2028, according to a recent SEC filing. This extension reflects the company’s ongoing efforts to optimize operational efficiency and…
- [Xencor: first $52.5M payment from Alexion due August 2026](https://www.ainvest.com/news/xencor-52-5m-payment-alexion-due-august-2026-2607) — AInvest Wire, Jul 29, 2026
  Xencor Inc. (XNCR) is set to receive a $52.5 million milestone payment from Alexion Pharmaceuticals in August 2026, as part of their ongoing collaboration agreement. The payment is tied to the achievement of specific developmental and regulatory milestones related to a jointly developed therapeutic…
- [Xencor to receive $105M from Alexion in royalty settlement](https://www.ainvest.com/news/xencor-receive-105m-alexion-royalty-settlement-2607) — AInvest Wire, Jul 29, 2026
- [Xencor shares fall 13%](https://www.ainvest.com/news/xencor-shares-fall-13-2505) — AInvest Wire, May 6, 2025
  Xencor shares fall 13% Xencor (NASDAQ: XNCR) shares experienced a notable 13% decline on May 7, 2025, despite reporting positive interim results from a first-in-human study of XmAb942, an anti-TL1A antibody for inflammatory bowel disease. The study showed promising safety and efficacy data, with…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).